VTE (VENOUS THROMBOEMBOLISM)
Clinical trials for VTE (VENOUS THROMBOEMBOLISM) explained in plain language.
Never miss a new study
Get alerted when new VTE (VENOUS THROMBOEMBOLISM) trials appear
Sign up with your email to follow new studies for VTE (VENOUS THROMBOEMBOLISM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill vs. shot: new hope for preventing deadly clots in cancer patients
Prevention Recruiting nowThis study is testing if blood thinner pills (apixaban or rivaroxaban) are as safe and effective as standard daily shots (low-molecular-weight heparin) at preventing dangerous blood clots in people being treated for blood cancers like leukemia, lymphoma, or multiple myeloma. Abou…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Cancer patients test easier blood thinner dose to stop deadly clots
Prevention Recruiting nowThis study aims to find the best way to use a common blood thinner (apixaban) to prevent dangerous blood clots in cancer patients who are at moderate risk. About 1,000 patients starting cancer treatment will be randomly assigned to take the standard twice-daily dose, a new once-d…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: PHASE3 • Sponsor: University of Vermont • Aim: Prevention
Last updated Mar 23, 2026 15:17 UTC